These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6766085)

  • 21. Glycosyltransferases as marker enzymes in neoplasia.
    Kessel D
    Prog Clin Biol Res; 1986; 204():21-30. PubMed ID: 3083424
    [No Abstract]   [Full Text] [Related]  

  • 22. Biochemical activities of lysosomal enzymes in leukemic cells: the characteristic alterations of the enzyme levels in childhood acute leukemia.
    Tanaka T; Kobayashi M; Horino N; Tanaka Y; Ueda K; Usui T
    Hiroshima J Med Sci; 1980 Sep; 29(3):125-32. PubMed ID: 6776075
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis of glycosphingolipid glycosyltransferase products on TLC plates by combined storage phosphor and immunostaining techniques.
    Stults CL; Sullivan MT; Macher BA; Johnston RF; Stack RJ
    Anal Biochem; 1994 May; 219(1):61-70. PubMed ID: 8059957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy.
    Cilloni D; Messa F; Arruga F; Defilippi I; Gottardi E; Fava M; Carturan S; Catalano R; Bracco E; Messa E; Nicoli P; Diverio D; Sanz MA; Martinelli G; Lo-Coco F; Saglio G
    Haematologica; 2008 Jun; 93(6):921-4. PubMed ID: 18443273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activities of fucosyltransferases in sera of leukaemic patients: platelet origin of serum alpha-6-L-fucosyltransferase.
    Kościelak J; Pacuszka T; Miller-Podraza H; Zdziechowska H
    Biochem Soc Trans; 1987 Aug; 15(4):603-6. PubMed ID: 3479356
    [No Abstract]   [Full Text] [Related]  

  • 26. Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals.
    Ommen HB; Nyvold CG; Braendstrup K; Andersen BL; Ommen IB; Hasle H; Hokland P; Ostergaard M
    Br J Haematol; 2008 Jun; 141(6):782-91. PubMed ID: 18410450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematological and biochemical changes in acute leukemic patients after chemotherapy.
    Rasheed A; Iqtidar A; Khan S
    Zhongguo Yao Li Xue Bao; 1996 May; 17(3):207-8. PubMed ID: 9812735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity analysis of three clonal and five non-clonal alpha 1,3-L-fucosyltransferases with sulfated, sialylated, or fucosylated synthetic carbohydrates as acceptors in relation to the assembly of 3'-sialyl-6'-sulfo Lewis x (the L-selectin ligand) and related complex structures.
    Chandrasekaran EV; Jain RK; Larsen RD; Wlasichuk K; DiCioccio RA; Matta KL
    Biochemistry; 1996 Jul; 35(27):8925-33. PubMed ID: 8688428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating endothelial cells in patients with acute myeloid leukemia.
    Wierzbowska A; Robak T; Krawczyńska A; Wrzesień-Kuś A; Pluta A; Cebula B; Smolewski P
    Eur J Haematol; 2005 Dec; 75(6):492-7. PubMed ID: 16313261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
    Doubek M; Palasek I; Pospisil Z; Borsky M; Klabusay M; Brychtova Y; Jurcek T; Jeziskova I; Krejci M; Dvorakova D; Mayer J
    Exp Hematol; 2009 Jun; 37(6):659-72. PubMed ID: 19463768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance and expression of vascular endothelial growth factor in serum of patients with acute leukemia].
    Xie JM; Qi ZH
    Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):183-5. PubMed ID: 12934374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
    Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the specificities of human blood group H gene-specified alpha 1,2-L-fucosyltransferase toward sulfated/sialylated/fucosylated acceptors: evidence for an inverse relationship between alpha 1,2-L-fucosylation of Gal and alpha 1,6-L-fucosylation of asparagine-linked GlcNAc.
    Chandrasekaran EV; Jain RK; Larsen RD; Wlasichuk K; Matta KL
    Biochemistry; 1996 Jul; 35(27):8914-24. PubMed ID: 8688427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
    de Lima M; van Besien K; Gajewski J; Khouri I; Andersson B; Korbling M; Champlin R; Giralt S
    Bone Marrow Transplant; 2000 Aug; 26(3):333-8. PubMed ID: 10967575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein C and antithrombin III in children with acute leukemia.
    Atlihan F; Karakaş Z; Batun S
    Turk J Pediatr; 1993; 35(1):45-51. PubMed ID: 8236517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoma-related alterations of glycosyltransferases in human tissues.
    Kuhns WJ; Schoentag R
    Cancer Res; 1981 Jul; 41(7):2767-72. PubMed ID: 6788361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
    Marcucci G; Mrózek K; Ruppert AS; Archer KJ; Pettenati MJ; Heerema NA; Carroll AJ; Koduru PR; Kolitz JE; Sterling LJ; Edwards CG; Anastasi J; Larson RA; Bloomfield CD
    J Clin Oncol; 2004 Jun; 22(12):2410-8. PubMed ID: 15197203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.